losartan has been researched along with Esophageal and Gastric Varices in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Esophageal and Gastric Varices: Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).
Excerpt | Relevance | Reference |
---|---|---|
"We performed a longitudinal study that included 23 consecutive patients with cirrhosis and esophageal varices who received 25 mg/day of losartan during 12 wk." | 3.73 | A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension. ( Castaño, G; García, SI; González, C; Pirola, CJ; Sookoian, S; Viudez, P, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brooks, R | 1 |
De, BK | 1 |
Bandyopadhyay, K | 1 |
Das, TK | 1 |
Das, D | 1 |
Biswas, PK | 1 |
Majumdar, D | 1 |
Mandal, SK | 1 |
Ray, S | 1 |
Dasgupta, S | 1 |
Sookoian, S | 1 |
Castaño, G | 1 |
García, SI | 1 |
Viudez, P | 1 |
González, C | 1 |
Pirola, CJ | 1 |
1 trial available for losartan and Esophageal and Gastric Varices
Article | Year |
---|---|
Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Esophageal and Gastric | 2003 |
2 other studies available for losartan and Esophageal and Gastric Varices
Article | Year |
---|---|
Management of varices in cirrhosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Esophageal and Gastric Varices; Humans; Hypertension, Porta | 2010 |
A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Chromatography, Hi | 2005 |